https://www.va.gov/formularyadvisor/DOC_PDF/MON_Triamcinolone_Acetonide_Extended-Release_ZILRETTA_Addendum_Nov_2022.pdf
This is an interesting document after Flexion tried again to get Zilretta into the VA formulary, the FDA are one thing but getting into formularies is going to be key, especially the likes of the VA.
You'd like to think iPPS's application would be more favourable with a different outcome!
https://www.va.gov/formularyadvisor/DOC_PDF/MON_Triamcinolone_Ace...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $321.4K | 1.618M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 90000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 16216 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |